Copper peptide comparison

GHK-Cu vs AHK-Cu: peptide identity, hair evidence, and topical-product safety

Compare GHK-Cu and AHK-Cu copper tripeptides with conservative guidance on ingredient identity, skin and scalp goals, hair-growth evidence limits, formula quality, and seller red flags.

Educational guideUpdated July 18, 2026

A safer way to compare GHK-Cu and AHK-Cu

Read the full ingredient name: glycyl-histidyl-lysine copper for GHK-Cu versus alanyl-histidyl-lysine copper for AHK-Cu. Do not assume every “copper peptide” serum contains either one.

Name the goal before shopping: cosmetic skin texture, scalp comfort, gradual shedding, patchy loss, sudden shedding, post-procedure care, or a clinician-reviewed topical plan.

Match claims to evidence: cell culture and isolated-follicle results can guide research, but they do not prove that an online serum regrows hair or treats a diagnosed skin condition.

Review the whole formula and routine: vehicle, concentration when disclosed, fragrance, preservatives, retinoids, acids, minoxidil, medicated shampoos, recent procedures, and irritation history.

Avoid research-use powders or vials, injectable or microneedling instructions, hidden ingredients, fake before-and-afters, and guarantees about hair regrowth, wound healing, collagen rebuilding, or age reversal.

Direct answer

GHK-Cu and AHK-Cu are different copper-binding tripeptide complexes, not interchangeable names for one proven hair or skin treatment. GHK-Cu contains glycyl-histidyl-lysine, while AHK-Cu contains alanyl-histidyl-lysine. GHK-Cu has a broader tissue-remodeling and cosmetic-research literature; the often-cited AHK-Cu hair study tested isolated human follicles and cultured dermal papilla cells, not a finished topical in a randomized scalp trial. Choose by the exact formula, goal, tolerance, source, and clinician review—not by “stronger peptide” or guaranteed-regrowth claims.

Ingredient identity

One amino-acid difference does not make GHK-Cu and AHK-Cu the same product

GHK-Cu is the copper complex of glycyl-L-histidyl-L-lysine; AHK-Cu is the copper complex of L-alanyl-L-histidyl-L-lysine. Their first amino acid differs—glycine in GHK and alanine in AHK—so product labels, evidence, concentration, vehicle, and intended use should be evaluated separately. GHK-Cu is discussed in a wider skin, tissue-remodeling, oxidative-stress, and cosmetic literature. AHK-Cu is especially visible in hair-peptide marketing, but marketing shorthand should not erase the narrower evidence base.

“Copper peptide,” “copper tripeptide,” GHK-Cu, and AHK-Cu are not reliable synonyms unless the ingredient label identifies the actual compound.
A Peptide12-listed GHK-Cu topical foam is not evidence for an unrelated AHK-Cu serum, research powder, injectable product, or multi-peptide cosmetic blend.
Neither ingredient should be described as an FDA-approved finished drug for androgenetic alopecia, alopecia areata, wounds, scars, wrinkles, or skin disease.

Evidence limits

The key AHK-Cu hair paper was ex vivo and in vitro—not a clinical regrowth trial

A 2007 study evaluated AHK-Cu in isolated human hair follicles outside the body and in cultured dermal papilla cells. It reported follicle elongation and dermal-papilla-cell proliferation under those laboratory conditions. That is useful mechanistic evidence, but it does not establish real-world benefit, dosing, long-term safety, or comparative effectiveness for a finished scalp product. Reviews discuss GHK-Cu across tissue-remodeling and cosmetic contexts, yet those findings also should not be transferred automatically to every concentration, vehicle, body site, or seller.

There is no cited head-to-head randomized trial showing that GHK-Cu or AHK-Cu is “better” for hair density, skin firmness, wrinkles, or recovery.
An isolated human follicle is human-derived tissue, but it is not the same as a treated person in a controlled scalp study.
Ask whether a claim comes from the exact peptide, route, formula, outcome, and population—or from a different compound, laboratory model, wound context, or broad review.

Skin and scalp goals

Diagnosis and routine fit matter more than peptide rankings

For cosmetic skin goals, GHK-Cu is usually considered as a topical copper-peptide ingredient within a broader routine. For hair concerns, AHK-Cu marketing often emphasizes the 2007 laboratory study, while GHK-Cu products may be positioned for scalp or follicle support. Neither approach should delay evaluation of sudden shedding, patchy hair loss, scalp inflammation, infection, scarring, thyroid or iron problems, medication effects, rapid weight change, pregnancy-related changes, or other causes that need diagnosis-first care.

If a clinician recommends minoxidil, finasteride, dutasteride, anti-inflammatory care, lab work, or another established pathway, do not replace it with a copper peptide without discussing the change.
For skin, stabilize eczema, rosacea, acne flares, infection, sunburn, or procedure aftercare before introducing another active topical.
For scalp use, review minoxidil, medicated shampoos, essential oils, retinoids, dyes, adhesives, and other products that can complicate irritation or shedding.

Formula safety and sourcing

The finished product matters more than the peptide name on the front label

Real-world tolerability depends on the entire formula, packaging, storage, concentration, application site, and concurrent routine. Cosmetic serums, clinician-directed topicals, compounded foams, and research-use materials have different quality questions. A legitimate seller should identify the ingredient, route, source, full formula, storage, expiration or beyond-use date when relevant, and who reviews reactions. Conservative use introduces one new topical at a time and avoids open skin or fresh procedure sites unless the treating clinician has cleared that exact product.

Stop and seek guidance for persistent burning, swelling, hives, blistering, crusting, eye symptoms, spreading redness, pus, fever, or worsening dermatitis.
Avoid injectable use, do-it-yourself mixing, microneedling delivery, research-grade powders, hidden concentrations, or instructions that bypass a licensed clinician.
Treat guaranteed regrowth, “collagen on demand,” wound-healing, scar-erasing, and age-reversal promises as seller red flags rather than clinical evidence.

Patient safety checklist

Questions to ask before choosing a GHK-Cu or AHK-Cu topical

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

✓

Does the label identify glycyl-histidyl-lysine copper, alanyl-histidyl-lysine copper, another copper peptide, or only a vague proprietary blend?

✓

Am I treating a cosmetic skin or scalp goal, or do sudden shedding, patchy loss, pain, scaling, scarring, infection, pigment change, or persistent rash need diagnosis first?

✓

Does the evidence match the exact peptide, concentration, vehicle, application site, outcome, and finished product being sold?

✓

Is the seller turning an isolated-follicle or cell-culture result into a guaranteed human hair-regrowth claim?

✓

What else is in the formula, and am I already using minoxidil, retinoids, acids, vitamin C, medicated shampoos, essential oils, or prescription topicals?

✓

Do eczema, rosacea, allergy history, pregnancy or breastfeeding questions, recent laser, peel, microneedling, transplant, or open skin change the timing?

✓

If the product is compounded or clinician-directed, who prescribes it, which pharmacy dispenses it, what storage or beyond-use instructions apply, and who reviews reactions?

✓

Can I introduce one product at a time, document tolerance, and stop rather than layering through burning, swelling, rash, or worsening scalp symptoms?

✓

Does the seller avoid research-use checkout, injections, do-it-yourself mixing, fake before-and-afters, and guaranteed hair, collagen, wound, scar, or anti-aging outcomes?

FAQs

Short answers for patients

What is the main difference between GHK-Cu and AHK-Cu?

GHK-Cu contains the tripeptide glycyl-histidyl-lysine bound to copper, while AHK-Cu contains alanyl-histidyl-lysine bound to copper. The first amino acid differs, and the compounds have different research histories. Do not assume evidence for one proves the other product works.

Is AHK-Cu proven to regrow hair in people?

The frequently cited 2007 AHK-Cu paper studied isolated human hair follicles outside the body and cultured dermal papilla cells. It was not a randomized scalp trial of a finished product, so it cannot establish clinical regrowth, long-term safety, or superiority over established hair-loss care.

Is GHK-Cu better than AHK-Cu for skin?

There is no head-to-head clinical evidence establishing a universal winner. GHK-Cu has a broader tissue-remodeling and cosmetic literature, while AHK-Cu is more narrowly discussed in hair-peptide research. Formula quality, goal, tolerance, other actives, and clinician review are more useful than a “stronger peptide” ranking.

Can I use GHK-Cu and AHK-Cu together?

Do not stack them automatically. Combining similar active topicals can increase cost and make irritation or benefit harder to interpret. Review the full formulas and introduce only one new product at a time unless a clinician recommends otherwise.

Are GHK-Cu and AHK-Cu FDA approved for hair loss or wrinkles?

No. They should not be described as FDA-approved finished drugs for hair loss, wrinkles, wounds, scars, or skin disease. Cosmetic and compounded products also need accurate identity, route, sourcing, labeling, and evidence boundaries.

When should hair loss be evaluated before trying a peptide serum?

Seek evaluation for sudden or patchy loss, scalp pain, scaling, pus, scarring, eyebrow or body-hair changes, rapid weight change, pregnancy-related changes, new medications, or possible thyroid, iron, autoimmune, or nutritional causes. A topical peptide should not delay diagnosis.

What online copper-peptide sellers should I avoid?

Avoid sellers offering research-use powders or vials for human use, injectable or microneedling protocols, hidden ingredient identity, no-prescription compounded products, fake before-and-afters, and guaranteed hair-regrowth, wound-healing, collagen, scar, or age-reversal outcomes.

Sources and related reading

Peptide12 pages use conservative educational language and authoritative sources where possible.

PubMed: AHK-Cu and human hair follicles ex vivo and dermal papilla cells in vitro PubMed: The human tripeptide GHK and tissue remodeling PubMed Central: GHK-Cu, oxidative stress, and aging review PubMed Central: 2026 overview of short peptides for hair loss FDA: Cosmetics under U.S. law FDA: Compounding and the FDA—Questions and Answers Peptide12: GHK-Cu topical foam guide Peptide12: GHK-Cu topical foam product Peptide12: GHK-Cu vs copper peptide serum Peptide12: GHK-Cu vs minoxidil Peptide12: GHK-Cu for hair-loss questions Peptide12: GHK-Cu side effects and safety Peptide12: Skin and hair peptide therapy Peptide12: How online peptide therapy works